Abstract
UK death rates from coronary heart disease are among the highest in the world. This is because the UK has high levels of standard risk factors and a low level of intervention on those risk factors. The most important modifiable cardiovascular risk factors are dyslipidaemia (particularly high LDL cholesterol and low HDL cholesterol), smoking, hypertension, glucose intolerance, and central obesity. Intervention strategies that do not target those individuals at highest cardiovascular risk are likely to be less cost effective. Global risk estimation is increasingly recognised by management guidelines as a clinically and cost effective means of guiding treatment. However, an over reliance on short term absolute risk may result in under treatment of young people (particularly women) at high relative risk and over treatment of older people (particularly men) at low relative risk.
Full Text
The Full Text of this article is available as a PDF (129.1 KB).
Figure 1 .
Does the Framingham risk function accurately predict CHD risk in a European population? Adapted from Haq et al,14 with permission.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Assmann Gerd, Cullen Paul, Schulte Helmut. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation. 2002 Jan 22;105(3):310–315. doi: 10.1161/hc0302.102575. [DOI] [PubMed] [Google Scholar]
- Barbir M., Wile D., Trayner I., Aber V. R., Thompson G. R. High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease. Br Heart J. 1988 Nov;60(5):397–403. doi: 10.1136/hrt.60.5.397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barker D. J. Fetal origins of coronary heart disease. BMJ. 1995 Jul 15;311(6998):171–174. doi: 10.1136/bmj.311.6998.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beral Valerie, Banks Emily, Reeves Gillian. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet. 2002 Sep 21;360(9337):942–944. doi: 10.1016/S0140-6736(02)11032-4. [DOI] [PubMed] [Google Scholar]
- Haq I. U., Ramsay L. E., Yeo W. W., Jackson P. R., Wallis E. J. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart. 1999 Jan;81(1):40–46. doi: 10.1136/hrt.81.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ramsay L., Williams B., Johnston G., MacGregor G., Poston L., Potter J., Poulter N., Russell G. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens. 1999 Sep;13(9):569–592. doi: 10.1038/sj.jhh.1000917. [DOI] [PubMed] [Google Scholar]
- Shaper A. G., Pocock S. J., Phillips A. N., Walker M. Identifying men at high risk of heart attacks: strategy for use in general practice. Br Med J (Clin Res Ed) 1986 Aug 23;293(6545):474–479. doi: 10.1136/bmj.293.6545.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tunstall-Pedoe H. The Dundee coronary risk-disk for management of change in risk factors. BMJ. 1991 Sep 28;303(6805):744–747. doi: 10.1136/bmj.303.6805.744. [DOI] [PMC free article] [PubMed] [Google Scholar]